Beiersdorf AG

02/24/2021 | Press release | Distributed by Public on 02/24/2021 04:02

Eucerin Launches First Medical Product with SPF 100

With its new innovation Eucerin ACTINIC CONTROL SPF100, Beiersdorf's dermocosmetics brand, is now offering new and effective sun protection which prevents actinic keratosis and non-melanoma skin cancer while also providing skin which is sensitive to the sun with effective protection from sun-induced skin damage. As such, it also serves as adjuvant treatment for patients already affected by actinic keratosis. 'The highly effective combination of high UVA/UVB protection and broad-spectrum filters offers our consumers maximum sun protection. As intensive protection is important in particular for skin, which is already damaged, we also tested its skin tolerance on patients with skin which is sensitive to the sun and with actinic keratosis,' explains Dr. Gitta Neufang, Chief Innovation and Medical Officer.

In addition to high sun protection and very good skin tolerance, the product stands out thanks to its texture - Eucerin ACTINIC CONTROL SPF100 is a fluid with a non-greasy, readily absorbed, and light texture, making it more pleasant for those affected to use. This new product underscores the parent company Beiersdorf's pronounced skincare expertise that also takes into account the special needs of consumers with dermatological indications.